Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : NIFTY NINE IN NINETY NINE PLUS ONE -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (377)	2/4/1999 4:41:00 PM
From: Arthur Radley	Respond to of 613

I don't want to beat the drum toooo much, but all should take a look at ATRX. Not high science, but good science and a huge market for their product.

To: Mike McFarland who wrote (377)	2/4/1999 6:18:00 PM
From: Steve Lokness	Read Replies (1) \| Respond to of 613

"The PathVysion HER-2 test is one of the first examples of genomic disease management for breast cancer, where a direct genetic test enables assessment of a patient for determination of the most appropriate therapy based upon their genetic profile." MYGN isn't the only one doing these test! Steve

To: Mike McFarland who wrote (377)	2/6/1999 9:02:00 AM
From: Mike McFarland	Read Replies (2) \| Respond to of 613

another gene...RRM1, and some reading material. eurekalert.org A new model of tumor suppressors? What may be most profound about RRM1 is that it could represent a new class of so-called "tumor suppressor genes," Bepler said. Most, if not all, tumor suppressor genes are classified as such because in their normal states they prevent cells from becoming cancerous. Trouble usually arises when one copy of the suppressing gene is deleted from the cell's DNA and the other copy is mutated, becoming inactive. I'm glad I picked biotech instead of something lame like the internuts in which to trade stocks...well, not from a financial standpoint, but so much interesting stuff--would be fun to get rich too off one of my stocks though and become a professional student, heheh, remember the 30-something slackers you used to see in class that never graduate, now that would be the life!